CIBRA Capital’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$926K Sell
7,058
-3,667
-34% -$469K 0.35% 26
2026
Q2
$2.03M Buy
+10,725
New +$1.59M 0.9% 21

Other funds holding ACLS

CIBRA Capital's ACLS Position: Q3 2026 in Review

CIBRA Capital reduced its Axcelis (ACLS) stake by 34% in Q3 2026, selling an estimated $469K and leaving 7,058 shares worth $926K. The position accounts for 0.35% of the portfolio, ranked #26.

CIBRA Capital first reported a position in ACLS in Q2 2026 and has held it in 2 quarters since. The position peaked at $2.03M in Q2 2026. 394 funds tracked by Wall St. Rank hold ACLS as of Q3 2026.

  • CIBRA Capital held 7,058 shares of Axcelis worth $926K as of Q3 2026.
  • CIBRA Capital sold 3,667 Axcelis shares in Q3 2026, an estimated $469K.
  • Axcelis made up 0.35% of CIBRA Capital's portfolio in Q3 2026, its #26 holding.
  • CIBRA Capital first reported a position in Axcelis in Q2 2026 and has held it in 2 quarters since.
  • CIBRA Capital's Axcelis position peaked at $2.03M in Q2 2026.
  • 394 funds tracked by Wall St. Rank held Axcelis as of Q3 2026.

Based on CIBRA Capital's 13F filing for Q3 2026, filed 19 Nov 2026.